Charles River Laboratories Share Holder Equity 2010-2024 | CRL

Charles River Laboratories share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Charles River Laboratories share holder equity for the quarter ending September 30, 2024 was $3.787B, a 14.39% increase year-over-year.
  • Charles River Laboratories share holder equity for 2023 was $3.602B, a 20.84% increase from 2022.
  • Charles River Laboratories share holder equity for 2022 was $2.981B, a 17.41% increase from 2021.
  • Charles River Laboratories share holder equity for 2021 was $2.539B, a 19.87% increase from 2020.
Charles River Laboratories Annual Share Holder Equity
(Millions of US $)
2023 $3,602
2022 $2,981
2021 $2,539
2020 $2,118
2019 $1,638
2018 $1,320
2017 $1,047
2016 $839
2015 $738
2014 $676
2013 $644
2012 $603
2011 $527
2010 $689
2009 $1,374
Charles River Laboratories Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $3,787
2024-06-30 $3,727
2024-03-31 $3,646
2023-12-31 $3,602
2023-09-30 $3,311
2023-06-30 $3,258
2023-03-31 $3,114
2022-12-31 $2,981
2022-09-30 $2,633
2022-06-30 $2,653
2022-03-31 $2,615
2021-12-31 $2,539
2021-09-30 $2,432
2021-06-30 $2,323
2021-03-31 $2,188
2020-12-31 $2,118
2020-09-30 $1,901
2020-06-30 $1,757
2020-03-31 $1,656
2019-12-31 $1,638
2019-09-30 $1,536
2019-06-30 $1,458
2019-03-31 $1,401
2018-12-31 $1,320
2018-09-30 $1,257
2018-06-30 $1,185
2018-03-31 $1,143
2017-12-31 $1,047
2017-09-30 $1,025
2017-06-30 $966
2017-03-31 $879
2016-12-31 $839
2016-09-30 $873
2016-06-30 $836
2016-03-31 $784
2015-12-31 $738
2015-09-30 $709
2015-06-30 $706
2015-03-31 $668
2014-12-31 $676
2014-09-30 $674
2014-06-30 $675
2014-03-31 $699
2013-12-31 $644
2013-09-30 $659
2013-06-30 $651
2013-03-31 $631
2012-12-31 $603
2012-09-30 $600
2012-06-30 $565
2012-03-31 $555
2011-12-31 $527
2011-09-30 $541
2011-06-30 $591
2011-03-31 $564
2010-12-31 $689
2010-09-30 $1,038
2010-06-30 $1,394
2010-03-31 $1,384
2009-12-31 $1,374
2009-09-30 $1,349
2009-06-30 $1,283
2009-03-31 $1,218
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00